institut pasteur of shanghai ips
How Inflammation Switches Off Tregs
DBC1, which has recently been shown to decrease the stability of immune suppressing transcription factor FOXP3, could be a therapeutic target for autoimmune diseases.
DBC1, which has recently been shown to decrease the stability of immune suppressing transcription factor FOXP3, could be a therapeutic target for autoimmune diseases.
